Plus, everything you need to know for the week ahead |
Finimize

👋 Hi John. Here’s what you need to know for the week ahead and what you might've missed last week.

Reach The Summit

The two-day Modern Investor Summit, the biggest event of the year for the world’s retail investing crowd, kicks off this week. And it’s never been more popular – or more important.

Reach The Summit

🔍 The focus this week: Modern investing

Interest rates are falling, geopolitical risks are rising, and this seems like an excellent time to assess what’s next. No coincidence, then, that 20,000 people have signed up to attend the Modern Investor Summit. The event – hosted by Finimize – brings together industry-leading experts and regular folks for two days of on-point market conversations. It’s where everyday investors can gain actionable insights and inspiration, and find out about the latest trends that could change how they trade.

The 2024 line-up includes Mellody Hobson, co-CEO and president of global asset management firm Ariel Investments, and member of the board of directors for both JPMorgan Chase and Starbucks. Oh, and she’s also a former chair of the board at DreamWorks and a former member of the board of Estée Lauder. Yep: she’s the kind of business pro who puts “regular overachievers” to shame. She’ll share her insights on how to foster a long-term investment mindset, how to see short-term volatility for what it is, and the factors you need to consider when making strategic decisions.

Now, Vanguard Group is the second-biggest investment firm in the world. So it’s no small deal that President and Chief Investment Officer Gregory Davis is joining the summit. He’ll talk about his vision for Vanguard and offer insights into the firm's ETF strategy and the new funds it’s planning to launch.

And, look, a lot of the moves that investors make come down to human psychology. And when you understand your own patterns and tendencies, it can help you make way smarter decisions. That’s why Dan Ariely – the social scientist and best-selling author – is on the docket: he’ll break down why folks make the mistakes they do and help you detect your own biases.

All that, and an oracle too. Meredith Whitney, a.k.a. the "Oracle of Wall Street" will explain how you can use everyday data to help predict market trends. She’s got some simple techniques that can help you avoid the common pitfalls in data-driven strategies and make better-informed investment decisions in real-time.

Plus, pros from JPMorgan, Charles Schwab, and others, will headline sessions on just about every investing topic you can think of – alternative assets, private equity, AI startups, leveraged and inverse exchange-traded funds, even litigation investing. It’s the biggest event of the year for retail investors, after all.

Attendees will uncover the advantages (and risks) of leveraged and inverse ETFs, explore the outlook for 2025 and major trends for the next decade, and find out how AI-driven platforms are transforming retail investor decision-making. There’s even a session on how to build a winning portfolio with $10,000.

So find a minute to register (it’s free) and check out the schedule. And if you can’t watch the sessions live, don’t sweat it: you can catch up later. The recordings will be posted on youtube.com/@Finimizecom.

* Sponsored by Linqto

Race out of the blocks

A strong start lays the foundation for great potential.

Linqto provides opportunities to help you pursue your goals. The digital investment platform is offering $2,000 in credits when you sign up.

Linqto isn’t like every other investment platform: it specializes in private markets – meaning, it can help you invest while companies are still private.

With Linqto, you can build a portfolio of high-quality private companies with confidence, knowing that Linqto’s professionals have researched every firm available on its platform.

And you don’t need a mountain of cash to get started: you can begin investing with just $2,500 – that’s a fraction of the six-figure sums traditional private equity firms often ask for.

So sign up today and come off the blocks like you mean it.

Discover More

Investing with Linqto is speculative, illiquid, and involves risk of complete loss. No guarantee is made that a company will experience an IPO or any liquidity event. For accredited investors only. All service- or trademarks are the property of their respective owners. Linqto Bucks use is subject to limitations; see Terms & Conditions. 

When you support our sponsors, you support us. Thanks for that.

If you want your brand featured here, get in touch.

đź“… On the calendar

  • Monday: EU unemployment (October), US manufacturing activity (November).
  • Tuesday: US auto sales (November). Earnings: Salesforce. Modern Investor Summit (day one).
  • Wednesday: EU producer price index (October), US factory orders (October), US service sector activity (November). Modern Investor Summit (day two).
  • Thursday: EU retail sales (October), Japan household spending (October). Earnings: Docusign, Lululemon.
  • Friday: UK house price index (November), US jobs report (November), US consumer sentiment (December), China CPI (November).

👀 What you might’ve missed last week

US

  • The president-elect promised tariffs on goods from Canada, Mexico, and China.
  • A key inflation index cast new doubt over how fast interest rates might fall.
  • A new proposal would make millions more Americans eligible to receive weight-loss drugs.


Japan

  • The Japanese yen was boosted alongside expectations of a December interest rate hike.

✍️ What does all this mean?

The president-elect said the US would impose 25% tariffs on all goods from Canada and Mexico, and an additional 10% levy on stuff from China. The news shook up markets – sending automakers’ shares especially lower. Car makers from the US and elsewhere have built extensive factories in Mexico to take advantage of cheaper labor costs. The news provoked wider jitters too: tariffs generally spark an increase in inflation -– which, in turn, results in higher interest rates. That’s likely to slow US and global growth, creating key risks for stocks in 2025.

US consumer prices rose 2.3% in October, compared to the 2.1% the month before, according to the Federal Reserve’s (Fed’s) preferred inflation gauge. The acceleration could inspire some added caution among the central bank’s policymakers in December as they debate another possible interest rate trim. With the US economy still on relatively strong footing and its job market still robust, the market is betting on a go-slow approach from the Fed.

Millions of overweight Americans on Medicare or Medicaid would be eligible for popular weight-loss drugs like Ozempic, Wegovy, and Mounjaro. The drugs – made by Denmark-based Novo Nordisk and US-based Eli Lilly – cost nearly $1,000 a month. And according to estimates, the proposal could cost taxpayers about $35 billion over the next nine years. Still, it could be well worth the expense, as obesity causes other conditions that cost tens of billions to treat.

Japan’s currency, the yen, rose almost 3% against the US dollar last week, on expectations that the Bank of Japan would likely hike interest rates in December to cool the country’s overly warm inflation. And that’s because higher interest rates make a currency more attractive for international savers and investors. The jump in expectations also gave financial stocks a boost, because profits for banks and insurers tend to grow when rates rise.

Stay classy ✌️

Your Finimize Analyst team

* Sponsored by BioStem

Medical tech that’s saving lives – and making millions doing it

Biostem (BSEM) is on a mission to improve millions of lives by revolutionizing how we heal wounds.Its products are designed to help patients recover from major surgeries and treat chronic wounds, like diabetic foot ulcers.

And there’s a huge opportunity in that: the diabetic foot ulcer market alone was worth over $4 billion in 2021, and demand for advanced wound care solutions is growing.

BSEM’s allografts drove $82 million in revenue last quarter, so it’s no wonder analysts at Zacks Small-Cap Research raised BSEM’s stock estimate to $32.50.

With cutting-edge regenerative therapies, BSEM continues to push the boundaries of wound care innovation, making it a leader in this fast-growing market.

Want to explore how BSEM is healing the future? Find out more information here.

Learn More

This content is for US investors only, if you are not a US investor please ignore this content. This content is a paid advertisement for BioStem Technologies, Inc from Sideways Frequency and Finimize. This is not Finimize editorial content. Finimize received a fixed fee from Sideways Frequency for producing, hosting and promoting this content via 4 email sends on behalf of BioStem Technologies, Inc, totalling $16,000. Other than the compensation received for this service, Finimize and its principals are not affiliated with either Sideways Frequency or BioStem Technologies, Inc. Finimize and its principals have no ownership in BioStem Technologies, Inc.

The content on this page should not be taken as advice, an endorsement, or a recommendation from Finimize and its principals to buy or sell any security. Finimize and its principals have not evaluated the accuracy of any claims made on this page. Finimize and its principals recommend that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky and capital is at risk. Past performance is not indicative of future results.

🌍 Finimize Live

🤩 Grab your tickets...

All events in UK time.

🚀 2024 Modern Investor Summit: December 3rd and 4th

Spotlighted Sessions:

🔎 2025 Outlook: What’s Next for Investors?: 3:30pm, December 3rd

🏡 Alternative Assets: Identifying Opportunities in Healthcare, Sustainable Energy & Real Estate: 5pm, December 3rd

🤖 Investing in AI: Opportunities in Pre-IPO and Private Markets: 5:45pm, December 3rd

⚖️ Investing In Lawsuits: An Untapped Market for Individual Investors: 6:30pm, December 3rd

🦾 AI’s Impact on Investment Platforms: A New Era for Retail Investors: 7:15pm, December 3rd

🎓 Mastering ETFs To Capitalize On 2025’s Biggest Themes: 12:15pm, December 4th

đź’µ How To Build A Winning Portfolio With $10,000: 1pm, December 4th

⏸ Want to turn off the Weekly Review? Hit pause

To stop receiving all Finimize emails (including the daily newsletter) Unsubscribe

View in browser

Crafted by Finimize Ltd. | 280 Bishopsgate, London, EC2M 4AG

All content provided by Finimize Ltd. is for informational and educational purposes only and is not meant to represent trade or investment recommendations. You signed up to this mailing list at finimize.com or through one of our partners. © Finimize 2024